The Proteon Management Team

jaroslawdastych4
Prof. Jarosław Dastych, Ph. D.
Founder & CEO, Board Member

Professor Jarosław Dastych is the Founder, CEO and President of the Board of Proteon Pharmaceuticals S.A., an innovative biotechnology company developing alternatives to antibiotics in animal, plant and human health. Prof. Dastych received his PhD in Medical Biology from the Medical University of Łódź in 1991 and started his scientific career at the Polish Academy of Sciences in Lodz, Poland. For several years he worked at the US National Institute of Health (NIH) in Bethesda, USA. In 2000 Prof. Dastych established the first research laboratory at the newly created International Institute of Molecular and Cell Biology in Warsaw. In 2005 Prof. Dastych established Proteon Pharmaceuticals. The company has developed a unique bacteriophage platform technology for development of effective alternatives to solving and preventing bacterial disease in animal farming and aquaculture as well as egg production and poultry farming. Its research platform and products have won international recognition and numerous innovation awards. Prof. Dastych research interests range from immunology, toxicology and molecular biology to the development of novel diagnostic tools and bacteriophage-based or related treatment of disease. He has coordinated twelve European R&D projects. He is the author of over 40 publications in international scientific journals and has co-authored 4 biotechnology-related patents.

Management Team
Matthew Tebeau
COO, Board Member

Matthew Tebeau is the Chief Operating Officer of Proteon Pharmaceuticals where he is responsible for the company’s strategy, partnership collaborations and mission/vision. Matthew has over 25 years of leadership experience with a specialization in organizational development. He has investment, governance and advisory experience in technology, life sciences, as well as business and consumer services. Matthew is a graduate of Dartmouth College and has completed executive programs in leadership and innovation at Harvard Business School and IMD.